Argen X SE EV/EBIT
Cos'è EV/EBIT di Argen X SE?
EV/EBIT di Argen X SE è N/A
Qual è la definizione di EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT di aziende nel Health Care settore su NASDAQ rispetto a Argen X SE
Cosa fa Argen X SE?
Argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
Aziende con ev/ebit simili a Argen X SE
- Armadale Capital Plc ha EV/EBIT di N/A
- Royal Dutch Shell Plc ha EV/EBIT di N/A
- Katanga Mining ha EV/EBIT di N/A
- Timex India ha EV/EBIT di N/A
- Newmark Security plc ha EV/EBIT di N/A
- Sypris Solutions ha EV/EBIT di N/A
- Argen X SE ha EV/EBIT di N/A
- Bedford Metals Corp ha EV/EBIT di N/A
- Royal Dutch Shell Plc ha EV/EBIT di N/A
- Royal Helium ha EV/EBIT di N/A
- Danakali ha EV/EBIT di N/A
- Amrit ha EV/EBIT di N/A
- AIM5 Ventures ha EV/EBIT di N/A